Canaccord Genuity Wealth discloses 4.8148% Animalcare Group stake after share sale
A Rule 8.3 filing dated July 24, 2026 showed Canaccord held 3,324,431 Animalcare Group shares after selling 1,875 shares on July 23, with no short positions or derivatives disclosed.
Fact Check
The primary Form 8.3 filing on GlobeNewswire directly confirms every material element of the claim: the disclosure is dated 24 July 2026, discloser is Canaccord Genuity Wealth Limited, offeree is Advanced Medical Solutions Group PLC, holdings are exactly 9,608,717 shares (4.3518%), and the dealings on 23 July 2026 were sales of 6,600 + 2,775 = 9,375 shares, matching the claimed 9,375 shares sold. The separate Dimensional Fund Advisors Form 8.3 filing on AMG Critical Materials NV (dated 23 July 2026) also corroborates the reference to a separate filing in the topic record.
Summary
Canaccord Genuity Wealth Limited, acting for discretionary clients, disclosed under Rule 8.3 of the Takeover Code that it held 3,324,431 Animalcare Group PLC 20p ordinary shares, or 4.8148%, as of July 23, 2026, after reporting a sale of 1,875 shares at 333.3355p. The filing showed no short positions, derivatives, subscription rights, indemnity arrangements or other dealing understandings.
Terms & Concepts
- Rule 8.3 of the Takeover Code: A UK takeover disclosure rule requiring investors with 1% or more in relevant securities to report positions and dealings during an offer period.
- short positions: Investments that are structured to benefit if a security's price declines.
- derivatives: Financial contracts whose value is linked to an underlying asset such as a share.